ConsentPixel – Privacy · Verified

Regulator Enforcement · Health Data

Hims & Hers: When the FTC Sues Over Tracking Pixels

Most tracking-pixel cases come from private plaintiffs. This one came from the federal government. The FTC — joined by Utah and Los Angeles County — sued Hims & Hers over pixels that allegedly shared patients' sexual-health, mental-health, and weight-loss information with advertising platforms. It's a reminder that pre-consent tracking isn't only a lawsuit risk; it's an enforcement risk, and the stakes climb sharply when the data is health data.

CP ConsentPixel Team Updated October 2026 12 min read Status: active litigation
FTC + 2
federal, Utah, and LA County enforcers — not private plaintiffs
6+ platforms
ad networks the health data was allegedly shared with
2 fronts
health-data tracking and deceptive subscription billing (ROSCA)

Case snapshot

Matter
FTC, State of Utah & County of Los Angeles v. Hims & Hers Health, Inc.
Court
U.S. District Court, Northern District of California
Filed
July 29, 2026
Enforcers
Federal Trade Commission, State of Utah, County of Los Angeles (on behalf of California)
Legal theory
FTC Act §5 (unfair/deceptive practices), Restore Online Shoppers' Confidence Act (ROSCA), FTC Health Breach Notification Rule, state consumer-protection law
Tracking at issue
Tracking pixels and customer-list uploads alleged to share health information (sexual wellness, mental health, weight loss) with Meta, Snap, Microsoft, Pinterest, Reddit and X
Also alleged
Deceptive "free"/"$0 today" offers and hard-to-cancel recurring subscriptions billed earlier than expected
Relief sought
Permanent injunction and monetary relief
Status
Active litigation Hims & Hers calls the allegations "baseless" and says it will defend itself. No court has ruled.

The Hims & Hers case is the one that should worry you even if you've never heard of a CIPA demand letter. Every other case on the tracker is a private lawsuit — a plaintiff or a class seeking damages. This one is a government enforcement action: the Federal Trade Commission, joined by the State of Utah and Los Angeles County, sued the telehealth company in July 2026. The core allegation is familiar — tracking pixels shared sensitive user information with advertising platforms without proper consent — but the identity of the plaintiff changes everything. When regulators enforce the same pre-consent tracking that private plaintiffs sue over, and the data in question is health data, the exposure stops being a settlement line item and becomes an existential compliance problem.

Not legal advice. This is an educational summary of a government enforcement complaint, current as of October 2026. The allegations are unproven; no court has ruled, and Hims & Hers has stated it will defend itself and calls the allegations baseless. Nothing here asserts any company broke the law. Consult qualified counsel about your own obligations.

What the case is about

Filed July 29, 2026 in the Northern District of California, the complaint alleges that Hims & Hers — a telehealth company offering treatment for sensitive conditions — disclosed consumers' health information to third-party advertising platforms. According to the FTC, this happened through two mechanisms: tracking pixels embedded in the site that captured and transmitted user activity, and customer-list uploads sent to ad platforms for audience matching.

The data at issue is unusually sensitive. The complaint describes information touching sexual wellness, mental health, weight loss, and other conditions being shared with platforms including Meta, Snap, Microsoft, Pinterest, Reddit, and X. For a company whose entire value proposition is discretion around personal health, the allegation is that the discretion didn't extend to the ad stack. The FTC and its co-plaintiffs seek a permanent injunction and monetary relief.

The customer-list upload allegation deserves particular attention, because it's the half most businesses overlook. Everyone now knows a pixel on the page can leak data. Fewer think about the other direction: deliberately exporting a list of customers — emails, phone numbers, the fact that they're your customers — and uploading it to an ad platform to build a "lookalike" audience or retarget them. That's a server-side data transfer, invisible to anyone inspecting the website, and it carries the implicit signal "these people use a telehealth service." The complaint treats both mechanisms as part of the same disclosure failure. For any business, it's a reminder that the pixel on the page is only the visible half of the data-sharing picture; the marketing team's audience-matching uploads are the half that doesn't show up in a browser.

The detail that makes it matter

Two things separate this from the private pixel cases. First, the enforcer. A private class action ends, at worst, in a settlement fund. An FTC action can end in a consent order that dictates how a company must operate for years — mandated privacy programs, audits, deletion requirements, and penalties for non-compliance. The leverage is different in kind, not just degree.

Second, the data. This isn't IP addresses or click events; it's information a reasonable person would consider among the most private they have. The complaint's framing — that a company promised discretion and then routed health signals to advertisers — is the kind of consumer-deception narrative the FTC is built to pursue. It also lands against a 2026 backdrop where the aggressive reading of HHS's HIPAA tracking guidance had been scaled back in court, yet enforcement over health-data tracking continued anyway, because the FTC Act and state consumer-protection law don't depend on HIPAA at all. (We cover that dynamic in the healthcare pixel settlement roundup.)

Does your site leak intent before consent?

The conduct here is pixels transmitting sensitive signals before consent. ConsentPixel's free scanner shows exactly what your site sends to Meta, Google, and other platforms on page load — before a visitor agrees — so you can see your own exposure the way an enforcer would.

Scan my site free →

The legal theory — beyond CIPA

This case is on our CIPA tracker, but it's important to be precise: it is not a CIPA case. No §631, no §638.51. It runs on a different, arguably broader set of tools:

1FTC Act §5Prohibits "unfair or deceptive acts or practices." Promising privacy while sharing health data with advertisers is the textbook deception theory.
2Restore Online Shoppers' Confidence Act (ROSCA)Governs online subscriptions — clear disclosure, informed consent to charges, and a simple way to cancel.
3FTC Health Breach Notification RuleRequires certain health apps and services to notify consumers when identifiable health information is disclosed without authorization.
4State consumer-protection lawUtah and Los Angeles County add state-level claims, broadening the enforcement coalition.

Why include a non-CIPA case on a CIPA tracker? Because the conduct is the same conduct CIPA plaintiffs target — trackers sharing data before consent — and the case proves that conduct is actionable through many doors, not one. A business that has carefully armored itself against §631 claims but ignored the FTC Act has only locked one of several. The tracker exists to show the full threat surface, and Hims & Hers is the clearest example that the surface extends well past California's wiretap statute.

⚠ SB 690 is irrelevant here
California's SB 690 reform only touches the CIPA §638.51 pen-register theory. It has no effect on the FTC Act, ROSCA, the Health Breach Notification Rule, or state consumer-protection law. A business counting on CIPA reform to reduce its tracking exposure is protected against none of the theories in this case.

The second front: deceptive subscriptions

The complaint isn't only about pixels. It also targets Hims & Hers' billing practices — and this half is worth understanding even if you're not in health. The FTC alleges the company advertised "free" consultations and "Pay $0 today," then enrolled patients in recurring subscriptions "as soon as a provider wrote a prescription," without a clear chance to review or decline. It further alleges charges were processed roughly ten days earlier than consumers would reasonably expect, with cancellation required two days before that early date.

That's a ROSCA theory: the problem isn't charging for a subscription, it's the gap between what the checkout said and what actually happened to the customer's card. If that sounds familiar, it should — it's the same disclosure-versus-reality mismatch at the heart of the tracking claims. Whether the subject is data or dollars, the FTC's complaint tells one consistent story: the company's representations didn't match its conduct. Any business running "free trial" funnels or auto-renewing plans should read the ROSCA half as a direct warning.

It's worth pausing on why the FTC bundled these two complaints together, because the pairing is strategic. Dark patterns in a checkout and silent data-sharing in the page's background are, to a regulator, the same species of problem: a business shaping what the customer can see and understand so that the customer's apparent "agreement" isn't really informed. Framed that way, a hidden auto-renewal and a pre-consent pixel are two expressions of one failure — consent that looks obtained but wasn't. That framing is portable. It means a regulator who finds one kind of mismatch on your site has a ready-made reason to look for the other, and it means cleaning up only your trackers while leaving a misleading checkout (or vice versa) leaves the underlying theory intact.

How it fits the 2026 landscape

Hims & Hers extends the pattern seen across the tracker into a new enforcement lane.

DimensionPrivate pixel case (e.g. Forbes)Hims & Hers (this case)
Who brings itPrivate plaintiff / classFTC + state + county regulators
DataIPs, identifiersSexual-health, mental-health, weight-loss info
LawCIPA §631 / §638.51FTC Act, ROSCA, Health Breach Rule, state law
Worst-case outcomeSettlement fundConsent order + injunction + penalties
LessonThe same pre-consent tracking is actionable by regulators, not just plaintiffs — and SB 690 doesn't touch those theories.

What this means for your site

You don't have to be a telehealth company to take the lesson. The conduct — trackers transmitting sensitive or intent-revealing data before consent — is common across industries, and the FTC's authority reaches far beyond health.

1Enforcement is a separate risk from litigationEven a site that never gets a demand letter can draw regulatory scrutiny. Fixing pre-consent tracking addresses both at once.
2Sensitive-intent pages are the highest riskAnything that reveals a condition, a financial situation, or a personal circumstance deserves extra care about what fires before consent.
3Customer-list uploads count tooIt's not only client-side pixels. Uploading customer data to ad platforms for matching is part of the same allegation — audit that pipeline as well.
4Mind your subscription funnelIf you run free trials or auto-renewals, make the terms unmistakable and cancellation easy. ROSCA applies whether or not you handle health data.

Key takeaways

  • The government is the plaintiff. The FTC, Utah, and LA County sued Hims & Hers — regulators, not a private class.
  • The data is maximally sensitive. Sexual-health, mental-health and weight-loss information allegedly shared with six-plus ad platforms.
  • It's not a CIPA case. It runs on the FTC Act, ROSCA, the Health Breach Notification Rule, and state law — proof the conduct is actionable through many doors.
  • SB 690 offers no cover. None of these theories are affected by California's CIPA reform.
  • Two warnings in one. Pre-consent tracking and deceptive subscription billing — audit both.

Frequently asked questions

What is the FTC's case against Hims & Hers about?

The FTC, joined by Utah and Los Angeles County, sued Hims & Hers in July 2026, alleging the telehealth company shared consumers' health information — covering sexual wellness, mental health, and weight loss — with advertising platforms including Meta, Snap, Microsoft, Pinterest, Reddit, and X, through tracking pixels and customer-list uploads. The complaint also targets allegedly deceptive subscription billing. The company calls the allegations baseless and says it will defend itself; no court has ruled.

Is this a CIPA lawsuit?

No. Despite appearing on our CIPA tracker, it does not use CIPA. It runs on the FTC Act (Section 5), the Restore Online Shoppers' Confidence Act (ROSCA), the FTC's Health Breach Notification Rule, and state consumer-protection law. We include it because the underlying conduct — trackers sharing data before consent — is the same conduct CIPA plaintiffs target, which shows that this behavior is actionable through multiple legal theories, not just CIPA.

Why does it matter that a regulator brought the case?

Because the consequences differ. A private class action typically ends in a settlement fund. A government enforcement action can end in a consent order that dictates how a company must operate for years — mandated privacy programs, audits, data-deletion requirements — plus injunctions and penalties. Regulatory enforcement is a distinct risk from private litigation, and addressing pre-consent tracking helps with both.

I'm not in healthcare — does this apply to me?

Parts of it directly. The FTC Act and ROSCA are not health-specific. Any business sharing user data with ad platforms before consent, or running "free trial" and auto-renewal funnels with unclear terms, is exposed to the same theories. The health-data angle raises the stakes, but the core lessons — align your disclosures with your actual data flows, and make subscriptions transparent — apply across industries.

Does SB 690 reduce this kind of exposure?

No. SB 690 only affects the CIPA Section 638.51 pen-register theory. It has no bearing on the FTC Act, ROSCA, the Health Breach Notification Rule, or state consumer-protection law — all of which this case relies on. A business relying on CIPA reform to reduce tracking risk is not protected against any of the theories here.

What should I check on my own site?

Start with what fires before consent — especially on pages that reveal sensitive intent (health, finance, personal circumstances). Then audit whether you upload customer lists to ad platforms, and review your subscription funnel for clear terms and easy cancellation. A privacy scan surfaces the client-side tracking piece quickly; the data-upload and billing pieces require an internal review.

The bottom line

Hims & Hers is the case that widens the frame. Every other entry on the tracker says "a plaintiff might sue you." This one says "a regulator might come for you" — over the same pre-consent tracking, through laws that have nothing to do with CIPA, with health data turning an ordinary mistake into a serious one.

The protective move doesn't change: make sure nothing sensitive leaves your site before a visitor consents, and make sure your checkout tells the truth. Those two habits answer the pixel claim and the subscription claim at once — and they're the same habits that keep private plaintiffs away too.

See what your site shares before consent

Scan your site and see exactly what it transmits to ad platforms on page load — before a visitor agrees. It's the conduct at the center of this case.

Scan my site free →
14-day trial · no credit card required
CP

ConsentPixel Team

Website privacy & consent compliance

ConsentPixel tracks both private litigation and regulatory enforcement around website tracking, and helps operators fix the pre-consent data sharing that draws both.

Sources & disclaimer. Facts drawn from the public FTC enforcement complaint against Hims & Hers Health, Inc. (N.D. Cal., filed July 29, 2026) and FTC announcements, current as of October 2026. The allegations are unproven; no court has ruled, and Hims & Hers calls them baseless and intends to defend. Private class actions over similar conduct may also be pending. This article is general information, not legal advice.
Scroll to Top